Omeflox BM Eye Ointment is a combination ophthalmic preparation containing Betamethasone 0.1% w/w, a potent corticosteroid, and Ofloxacin 0.3% w/w, a broad-spectrum fluoroquinolone antibiotic. This formulation is indicated for the treatment of inflammatory ocular conditions accompanied by bacterial infections or where there is a risk of secondary bacterial infection. Betamethasone exerts anti-inflammatory, anti-allergic, and immunosuppressive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing ocular inflammation, edema, and discomfort. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, resulting in bactericidal activity against a wide range of gram-positive and gram-negative pathogens. Omeflox BM Eye Ointment is typically used in conditions such as bacterial conjunctivitis, keratitis, blepharitis, and post-operative ocular inflammation with suspected or confirmed bacterial involvement. The ointment base provides prolonged contact time with the ocular surface, enhancing drug absorption and therapeutic efficacy. Caution is advised in patients with viral, fungal, or mycobacterial eye infections, as corticosteroids may exacerbate these conditions. Use should be under strict medical supervision to monitor for potential side effects such as increased intraocular pressure, delayed wound healing, or secondary infections.